FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Ingeborg Zehbe

Research Profile

Living Beings

Disorders

Chemicals & Drugs

Procedures

Anatomy

Phenomena

Polymorphism, Single-Stranded Conformational

Geographic Areas

Sweden

Co-author Network

Publications

TOP 3
Samuel Pichardo; Melissa Togtema; Ingeborg Zehbe; Robert Jackson; Laura Curiel
Influence of cell line and cell cycle phase on sonoporation transfection efficiency in cervical carcinoma cells under the same physical conditions.
Robert Jackson; Melissa Togtema; Ingeborg Zehbe
Subcellular localization and quantitation of the human papillomavirus type 16 E6 oncoprotein through immunocytochemistry detection.
Sarah Niccoli; Christina Richard; Suraj Abraham; Ingeborg Zehbe
The Asian-American E6 variant protein of human papillomavirus 16 alone is sufficient to promote immortalization, transformation, and migration of primary human foreskin keratinocytes.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Ingeborg Zehbe (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Samuel Pichardo; Melissa Togtema; Ingeborg Zehbe; Robert Jackson; Laura Curiel
Influence of cell line and cell cycle phase on sonoporation transfection efficiency in cervical carcinoma cells under the same physical conditions.
IEEE transactions on ultrasonics, ferroelectrics, and frequency control 2013;60(2):432-5.
2013: Robert Jackson; Melissa Togtema; Ingeborg Zehbe
Subcellular localization and quantitation of the human papillomavirus type 16 E6 oncoprotein through immunocytochemistry detection.
Virology 2013;435(2):425-32.
2012: Sarah Niccoli; Christina Richard; Suraj Abraham; Ingeborg Zehbe
The Asian-American E6 variant protein of human papillomavirus 16 alone is sufficient to promote immortalization, transformation, and migration of primary human foreskin keratinocytes.
Journal of virology 2012;86(22):12384-96.
2012: Jeff Werner; Ingeborg Zehbe; Correne A Decarlo; Nicholas Escott; Marina Ulanova
Expression of integrins and Toll-like receptors in cervical cancer: effect of infectious agents.
Innate immunity 2012;18(1):55-69.
2012: Melissa Togtema; Laura Curiel; Robert Jackson; Paul F Lambert; Samuel Pichardo; Ingeborg Zehbe
Sonoporation delivery of monoclonal antibodies against human papillomavirus 16 E6 restores p53 expression in transformed cervical keratinocytes.
PloS one 2012;7(11):e50730.
2012: Correne A DeCarlo; Nicholas G Escott; Robert Jackson; Sarah Niccoli; Bruce Rosa; Ingeborg Zehbe
Toll-like receptor transcriptome in the HPV-positive cervical cancer microenvironment.
Clinical & developmental immunology 2012;2012():785825.
2011: Ingeborg Zehbe; Michael Campbell; Lynne Hampson; Kyle F Lee; Christina Richard; Ian N Hampson
Lopinavir shows greater specificity than zinc finger ejecting compounds as a potential treatment for human papillomavirus-related lesions.
Antiviral research 2011;91(2):161-6.
2011: Ingeborg Zehbe; Alberto Severini; Bruce Weaver; Diane Bannon; Crystal Bell; Sandra Crawford; Nicholas Escott; Helle Moeller; Natalie Paavola
Feasibility of self-sampling and human papillomavirus testing for cervical cancer screening in First Nation women from Northwest Ontario, Canada: a pilot study.
BMJ open 2011;1(1):e000030.
2011: Ingeborg Zehbe; Paul F Lambert; Hava Lichtig; Massimo Tommasino; Ashley Westerback; Levana Sherman
Rare human papillomavirus 16 E6 variants reveal significant oncogenic potential.
Molecular cancer 2011;10():77.
2011: Gavin Batman; Lynne Hampson; Anthony W Oliver; Christina Richard; Ingeborg Zehbe; Ian N Hampson
Lopinavir up-regulates expression of the antiviral protein ribonuclease L in human papillomavirus-positive cervical carcinoma cells.
Antiviral therapy 2011;16(4):515-25.
2010: Correne A DeCarlo; Alberto Severini; Lutz Edler; Nicholas G Escott; Paul F Lambert; Marina Ulanova; Ingeborg Zehbe
IFN-κ, a novel type I IFN, is undetectable in HPV-positive human cervical keratinocytes.
Laboratory investigation; a journal of technical methods and pathology 2010;90(10):1482-91.
2009: Ingeborg Zehbe; Christina Richard; Correne A DeCarlo; Anny Shai; Paul F Lambert; Hava Lichtig; Massimo Tommasino; Levana Sherman
Human papillomavirus 16 E6 variants differ in their dysregulation of human keratinocyte differentiation and apoptosis.
Virology 2009;383(1):69-77.
2008: Correne A DeCarlo; Nicholas G Escott; Julieta Werner; Kerry Robinson; Paul F Lambert; R David Law; Ingeborg Zehbe
Gene expression analysis of interferon kappa in laser capture microdissected cervical epithelium.
Analytical biochemistry 2008;381(1):59-66.
2008: K Lee; I Magalhaes; C Clavel; Jenny Briolat; P Birembaut; M Tommasino; Ingeborg Zehbe
Human papillomavirus 16 E6, L1, L2 and E2 gene variants in cervical lesion progression.
Virus research 2008;131(1):106-10.
2007: Yulia Asadurian; Helena Kurilin; Hava Lichtig; Anna Jackman; Pinhas Gonen; Massimo Tommasino; Ingeborg Zehbe; Levana Sherman
Activities of human papillomavirus 16 E6 natural variants in human keratinocytes.
Journal of medical virology 2007;79(11):1751-60.
2007: Ingeborg Zehbe; Andreas M Kaufmann; Markus Schmidt; Hanni Hohn; Markus J Maeurer
Human papillomavirus 16 E6-specific CD45RA+ CCR7+ high avidity CD8+ T cells fail to control tumor growth despite interferon-gamma production in patients with cervical cancer.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2007;30(5):523-32.
2007: Hanni Höhn; Cornelius Kortsik; Ingeborg Zehbe; Walter E Hitzler; K Kayser; Kirsten Freitag; Claudia Neukirch; P Andersen; Timothy Doherty; Markus J Maeurer
MHC class II tetramer guided detection of Mycobacterium tuberculosis-specific CD4+ T cells in peripheral blood from patients with pulmonary tuberculosis.
Scandinavian journal of immunology 2007;65(5):467-78.
2006: Ingeborg Zehbe; M Schmidt; Markus J Maeurer; Cornelia Leo; Michael Höckel; Henryk Pilch
Different T-cell receptor (TCR) zeta chain expression in cervical cancer and its precursor lesions.
Zentralblatt für Gynäkologie 2006;128(5):266-70.
2006: Hava Lichtig; Meirav Algrisi; Liat Edri Botzer; Tal Abadi; Yulia Verbitzky; Anna Jackman; Massimo Tommasino; Ingeborg Zehbe; Levana Sherman
HPV16 E6 natural variants exhibit different activities in functional assays relevant to the carcinogenic potential of E6.
Virology 2006;350(1):216-27.
2006: Martha Grodzki; Guillaume Besson; Christine Clavel; Annie Arslan; Silvia Franceschi; Philippe Birembaut; Massimo Tommasino; Ingeborg Zehbe
Increased risk for cervical disease progression of French women infected with the human papillomavirus type 16 E6-350G variant.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(4):820-2.
2005: Ingeborg Zehbe; Hanni Höhn; Henryk Pilch; Claudia Neukirch; Kirsten Freitag; Markus J Maeurer
Differential MHC class II component expression in HPV-positive cervical cancer cells: implication for immune surveillance.
International journal of cancer. Journal international du cancer 2005;117(5):807-15.
2005: Sebastian Oerke; Hanni Höhn; Ingeborg Zehbe; Henryk Pilch; Karl-Heinz Schicketanz; Walter E Hitzler; Claudia Neukirch; Kirsten Freitag; Markus J Maeurer
Naturally processed and HLA-B8-presented HPV16 E7 epitope recognized by T cells from patients with cervical cancer.
International journal of cancer. Journal international du cancer 2005;114(5):766-78.
2005: Glenn Tully; Cornelius Kortsik; Hanni Höhn; Ingeborg Zehbe; Walter E Hitzler; Claudia Neukirch; Kirsten Freitag; Klaus Kayser; Markus J Maeurer
Highly focused T cell responses in latent human pulmonary Mycobacterium tuberculosis infection.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(4):2174-84.
2004: Federica Gemignani; Stefano Landi; Amelie Chabrier; Anouk Smet; Ingeborg Zehbe; Federico Canzian; Massimo Tommasino
Generation of a DNA microarray for determination of E6 natural variants of human papillomavirus type 16.
Journal of virological methods 2004;119(2):95-102.
2004: Sandra Caldeira; Raffaele Filotico; Rosita Accardi; Ingeborg Zehbe; Silvia Franceschi; Massimo Tommasino
p53 mutations are common in human papillomavirus type 38-positive non-melanoma skin cancers.
Cancer letters 2004;209(1):119-24.
2004: angelo paradiso; Girolamo Ranieri; Baldassarre Stea; Alfredo Zito; Ingeborg Zehbe; Massimo Tommasino; Luciano Grammatica; Mario De Lena
Altered p16INK4a and Fhit expression in carcinogenesis and progression of human oral cancer.
International journal of oncology 2004;24(2):249-55.
2003: Ingeborg Zehbe; Joannis Mytilineos; Ingrid Wikström; Rudi Henriksen; Lutz Edler; Massimo Tommasino
Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women.
Human immunology 2003;64(5):538-42.
2003: Massimo Tommasino; Rosita Accardi; Sandra Caldeira; Wen Dong; Ilaria Malanchi; Anouk Smet; Ingeborg Zehbe
The role of TP53 in Cervical carcinogenesis.
Human mutation 2003;21(3):307-12.
2003: Sandra Caldeira; Ingeborg Zehbe; Rosita Accardi; Ilaria Malanchi; Wen Dong; Marianna Giarrè; Ethel-Michele de Villiers; Raffaele Filotico; Petra Boukamp; Massimo Tommasino
The E6 and E7 proteins of the cutaneous human papillomavirus type 38 display transforming properties.
Journal of virology 2003;77(3):2195-206.
2002: C Kämmer; Massimo Tommasino; S Syrjänen; Hajo Delius; U Hebling; Ursula Warthorst; Herbert Pfister; Ingeborg Zehbe
Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease.
British journal of cancer 2002;86(2):269-73.
2001: Ingeborg Zehbe; R Tachezy; Joannis Mytilineos; Gianfranco Voglino; I Mikyskova; Hajo Delius; Antonella Marongiu; Lutz Gissmann; Erik Wilander; Massimo Tommasino
Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes.
International journal of cancer. Journal international du cancer 2001;94(5):711-6.
2001: Ingeborg Zehbe; Gianfranco Voglino; Erik Wilander; Hajo Delius; Antonella Marongiu; Lutz Edler; Fritz Klimek; S Andersson; Massimo Tommasino
p53 codon 72 polymorphism and various human papillomavirus 16 E6 genotypes are risk factors for cervical cancer development.
Cancer research 2001;61(2):608-11.
1999: Ingeborg Zehbe; Gianfranco Voglino; E Wilander; F Genta; M Tommasino
Codon 72 polymorphism of p53 and its association with cervical cancer.
Lancet 1999;354(9174):218-9.
1999: A Strand; S Andersson; Ingeborg Zehbe; Erik Wilander
HPV prevalence in anal warts tested with the MY09/MY11 SHARP Signal system.
Acta dermato-venereologica 1999;79(3):226-9.
1999: Ingeborg Zehbe; A Rätsch; Marianna Alunni-Fabbroni; A Burzlaff; E Bakos; Matthias Dürst; Erik Wilander; Massimo Tommasino
Overriding of cyclin-dependent kinase inhibitors by high and low risk human papillomavirus types: evidence for an in vivo role in cervical lesions.
Oncogene 1999;18(13):2201-11.
1998: Ingeborg Zehbe; Gianfranco Voglino; Hajo Delius; E Wilander; M Tommasino
Risk of cervical cancer and geographical variations of human papillomavirus 16 E6 polymorphisms.
Lancet 1998;352(9138):1441-2.
1998: Ingeborg Zehbe; Erik Wilander; Hajo Delius; Massimo Tommasino
Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype.
Cancer research 1998;58(4):829-33.
1997: Ingeborg Zehbe; Erik Wilander
Human papillomavirus infection and invasive cervical neoplasia: a study of prevalence and morphology.
The Journal of pathology 1997;181(3):270-5.
1997: Ingeborg Zehbe; Erik Wilander
Nonisotopic ELISA-based detection of human papillomavirus-amplified DNA.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 1997;10(3):188-91.
1997: A Strand; Erik Wilander; Ingeborg Zehbe; Eva Rylander
High risk HPV persists after treatment of genital papillomavirus infection but not after treatment of cervical intraepithelial neoplasia.
Acta obstetricia et gynecologica Scandinavica 1997;76(2):140-4.
1996: Ingeborg Zehbe; Jan Sällström; Magnus Evander; K Edlund; Eva Rylander; G Wadell; Erik Wilander
Nonradioisotopic detection and typing of human papillomaviruses by use of polymerase chain reaction and single-strand conformation polymorphism.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 1996;5(3):206-13.
1996: Ingeborg Zehbe; Erik Wilander
Two consensus primer systems and nested polymerase chain reaction for human papillomavirus detection in cervical biopsies: A study of sensitivity.
Human pathology 1996;27(8):812-5.
1996: A Strand; Eva Rylander; Erik Wilander; Ingeborg Zehbe; W Kraaz
Histopathologic examination of penile epithelial lesions is of limited diagnostic value in human papillomavirus infection.
Sexually transmitted diseases 1996;23(4):293-8.
1996: Ingeborg Zehbe; Eva Rylander; K Edlund; G Wadell; Erik Wilander
Detection of human papillomavirus in cervical intra-epithelial neoplasia, using in situ hybridization and various polymerase chain reaction techniques.
Virchows Archiv : an international journal of pathology 1996;428(3):151-7.
1996: Ingeborg Zehbe; A Strand; K L Chua; Erik Wilander
Cytological evaluation and molecular human papillomavirus test of cervical scrapings from women treated for condyloma.
Gynecologic and obstetric investigation 1996;42(2):128-32.
1995: A Strand; Eva Rylander; Erik Wilander; Ingeborg Zehbe
HPV infection in male partners of women with squamous intraepithelial neoplasia and/or high-risk HPV.
Acta dermato-venereologica 1995;75(4):312-6.
1995: A Strand; Erik Wilander; Ingeborg Zehbe; W Kraaz; Eva Rylander
Vulvar papillomatosis, aceto-white lesions, and normal-looking vulvar mucosa evaluated by microscopy and human papillomavirus analysis.
Gynecologic and obstetric investigation 1995;40(4):265-70.
1993: Jan Sällström; Ingeborg Zehbe; M Alemi; Erik Wilander
Pitfalls of in situ polymerase chain reaction (PCR) using direct incorporation of labelled nucleotides.
Anticancer research 1993;13(4):1153.
1993: Ingeborg Zehbe; Eva Rylander; A Strand; Erik Wilander
Use of Probemix and OmniProbe biotinylated cDNA probes for detecting HPV infection in biopsy specimens from the genital tract.
Journal of clinical pathology 1993;46(5):437-40.
1992: Ingeborg Zehbe; Gerhard W Hacker; Eva Rylander; Jan Sällström; Erik Wilander
Detection of single HPV copies in SiHa cells by in situ polymerase chain reaction (in situ PCR) combined with immunoperoxidase and immunogold-silver staining (IGSS) techniques.
Anticancer research 1992;12(6B):2165-8.
1992: Ingeborg Zehbe; Eva Rylander; A Strand; Erik Wilander
In situ hybridization for the detection of human papillomavirus (HPV) in gynaecological biopsies. A study of two commercial kits.
Anticancer research 1992;12(5):1383-8.